Tom Keith-Roach, president of AstraZeneca UKsaid Wednesday that they are preparing to make more than 2 million doses of their coronavirus vaccine available in the UK shortly, as reported by Reuters.
The company reported that the production of the vaccine is a 3-4 month process and that it can offer great visibility of the supply schedule until the end of the first quarter.
“Process optimization can make over 2 million doses a week possible for the UKbut I can’t commit to that, “Keith-Roach said.
COVID outbreaks are hampering the vaccine development workforce, the AstraZeneca president justified. He added that they have requested that vaccine developers and trial staff have priority to receive an injection.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
